{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:28:27Z","timestamp":1776212907424,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1186\/s43141-023-00583-w","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T04:02:24Z","timestamp":1699934544000},"page":"117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bioinformatics analysis of multi-epitope peptide vaccines against Hepatitis C virus: a molecular docking study"],"prefix":"10.1016","volume":"21","author":[{"given":"Ashraf M.","family":"Muhammad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8837-2065","authenticated-orcid":false,"given":"Ghada M.","family":"Salum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai Abd El","family":"Meguid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basma E.","family":"Fotouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reham M.","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1186\/s43141-023-00583-w_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101626","article-title":"HCV virology and diagnosis","volume":"45","author":"Roger","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1186\/s43141-023-00583-w_bib2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM197504102921502","article-title":"Transfusion-associated hepatitis not due to viral hepatitis type A or B","volume":"292","author":"Feinstone","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1186\/s43141-023-00583-w_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1186\/s43141-023-00583-w_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/hae.14607","article-title":"Prevalence and risk factors for hepatocellular carcinoma in individuals with haemophilia in the era of direct-acting antiviral agents: A national inpatient sample study","volume":"28","author":"Yang","year":"2022","journal-title":"Haemophilia"},{"key":"10.1186\/s43141-023-00583-w_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-53051-2","article-title":"Impact of direct acting antivirals on survival in patients with chronic hepatitis C and hepatocellular carcinoma","volume":"9","author":"Kamp","year":"2019","journal-title":"Sci Rep"},{"key":"10.1186\/s43141-023-00583-w_bib6","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.3748\/wjg.v26.i43.6770","article-title":"Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end","volume":"26","author":"Muzica","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1186\/s43141-023-00583-w_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/cmi.2014.127","article-title":"Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection","volume":"13","author":"Wong","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1186\/s43141-023-00583-w_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10119","article-title":"Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients","volume":"8","author":"Dawood","year":"2022","journal-title":"Heliyon"},{"key":"10.1186\/s43141-023-00583-w_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43141-021-00266-4","article-title":"Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation","volume":"19","author":"Salum","year":"2021","journal-title":"J Genet Eng Biotechnol"},{"key":"10.1186\/s43141-023-00583-w_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2174\/1389450116666150825111314","article-title":"Direct-acting antivirals for hepatitis C virus (HCV): the progress continues","volume":"18","author":"Feld","year":"2017","journal-title":"Current Drug Targets"},{"key":"10.1186\/s43141-023-00583-w_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621706","article-title":"Immunoinformatics design of multi-epitope peptide-based vaccine against Schistosoma mansoni using transmembrane proteins as a target","volume":"12","author":"Sanches","year":"2021","journal-title":"Front Immunol"},{"key":"10.1186\/s43141-023-00583-w_bib12","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3389\/fmicb.2017.02413","article-title":"Preclinical development and production of virus-like particles as vaccine candidates for hepatitis C","volume":"8","author":"Masavuli","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1186\/s43141-023-00583-w_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, progress, and challenges to hepatitis C vaccine development","volume":"156","author":"Bailey","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1186\/s43141-023-00583-w_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/vaccines8010090","article-title":"Hepatitis C virus vaccine: challenges and prospects","volume":"8","author":"Duncan","year":"2020","journal-title":"Vaccines"},{"key":"10.1186\/s43141-023-00583-w_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1186\/s43141-023-00583-w_bib16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","article-title":"Vaccination of chimpanzees against infection by the hepatitis C virus","volume":"91","author":"Choo","year":"1994","journal-title":"Proc Natl Acad Sci."},{"key":"10.1186\/s43141-023-00583-w_bib17","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/cid\/cis362","article-title":"Prospects for prophylactic and therapeutic vaccines against hepatitis C virus","volume":"55","author":"Feinstone","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s43141-023-00583-w_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059776","article-title":"A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1\/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans","volume":"8","author":"Law","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1186\/s43141-023-00583-w_bib19","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1021\/cb500121c","article-title":"Role of N-linked glycans in the interactions of recombinant HCV envelope glycoproteins with cellular receptors","volume":"9","author":"Chen","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1186\/s43141-023-00583-w_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41541-023-00635-9","article-title":"Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity","volume":"8","author":"Patra","year":"2023","journal-title":"Npj Vaccines"},{"key":"10.1186\/s43141-023-00583-w_bib21","first-page":"1","article-title":"Prediction of B-cell epitopes using evolutionary information and propensity scales","volume":"14","author":"Lin","year":"2013","journal-title":"BioMed Central."},{"key":"10.1186\/s43141-023-00583-w_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"key":"10.1186\/s43141-023-00583-w_bib23","doi-asserted-by":"crossref","unstructured":"Kalita P, Tripathi T (2022) Methodological advances in the design of peptide-based vaccines. Drug Discov Today","DOI":"10.1016\/j.drudis.2022.03.004"},{"key":"10.1186\/s43141-023-00583-w_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.arcmed.2021.01.004","article-title":"Immunoinformatics approach for the identification and characterization of T cell and B cell epitopes towards the peptide-based vaccine against SARS-CoV-2","volume":"52","author":"Chakraborty","year":"2021","journal-title":"Arch Med Res"},{"key":"10.1186\/s43141-023-00583-w_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12875","article-title":"Development of tumour peptide vaccines: From universalization to personalization","volume":"91","author":"Ma","year":"2020","journal-title":"Scand J Immunol"},{"key":"10.1186\/s43141-023-00583-w_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/14760584.2020.1794832","article-title":"An overview of in silico vaccine design against different pathogens and cancer","volume":"19","author":"Kardani","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.1186\/s43141-023-00583-w_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-09199-w","article-title":"Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection","volume":"7","author":"Ali","year":"2017","journal-title":"Sci Rep"},{"key":"10.1186\/s43141-023-00583-w_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jiph.2020.12.006","article-title":"Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2","volume":"14","author":"Dawood","year":"2021","journal-title":"J Infect Public Health"},{"key":"10.1186\/s43141-023-00583-w_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/vaccines10040624","article-title":"Recent Advances in Vaccine Technology and Design","volume":"10","author":"Cianci","year":"2022","journal-title":"Vaccines"},{"key":"10.1186\/s43141-023-00583-w_bib30","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.drudis.2018.05.006","article-title":"Protein\u2013peptide docking: opportunities and challenges","volume":"23","author":"Ciemny","year":"2018","journal-title":"Drug Discovery Today"},{"key":"10.1186\/s43141-023-00583-w_bib31","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"10.1186\/s43141-023-00583-w_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1186\/s43141-023-00583-w_bib33","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.vaccine.2006.09.032","article-title":"Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties","volume":"25","author":"Doytchinova","year":"2007","journal-title":"Vaccine"},{"key":"10.1186\/s43141-023-00583-w_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v. 2\u2014a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J Mol Model"},{"key":"10.1186\/s43141-023-00583-w_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PloS One"},{"key":"10.1186\/s43141-023-00583-w_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196829","article-title":"In silico approaches for predicting the half-life of natural and modified peptides in blood","volume":"13","author":"Mathur","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1186\/s43141-023-00583-w_bib37","doi-asserted-by":"crossref","first-page":"W288","DOI":"10.1093\/nar\/gks419","article-title":"PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides","volume":"40","author":"Thevenet","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1186\/s43141-023-00583-w_bib38","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/ct500592m","article-title":"Improved PEP-FOLD approach for peptide and miniprotein structure prediction","volume":"10","author":"Shen","year":"2014","journal-title":"J Chem Theory Comput"},{"key":"10.1186\/s43141-023-00583-w_bib39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/prot.21505","article-title":"A coarse-grained protein force field for folding and structure prediction","volume":"69","author":"Maupetit","year":"2007","journal-title":"Proteins Struct Funct Bioinform."},{"key":"10.1186\/s43141-023-00583-w_bib40","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-Pdb Viewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1186\/s43141-023-00583-w_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/prot.25234","article-title":"Addressing recent docking challenges: A hybrid strategy to integrate template-based and free protein-protein docking","volume":"85","author":"Yan","year":"2017","journal-title":"Proteins Struct Funct Bioinform."},{"key":"10.1186\/s43141-023-00583-w_bib42","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein\u2013protein and protein\u2013DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1186\/s43141-023-00583-w_bib43","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat Protoc"},{"key":"10.1186\/s43141-023-00583-w_bib44","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.3390\/molecules27144518","article-title":"Novel Design of RNA Aptamers as Cancer Inhibitors and Diagnosis Targeting the Tyrosine Kinase Domain of the NT-3 Growth Factor Receptor Using a Computational Sequence-Based Approach","volume":"27","author":"Muhammad","year":"2022","journal-title":"Molecules"},{"key":"10.1186\/s43141-023-00583-w_bib45","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1186\/s43141-023-00583-w_bib46","unstructured":"Schrodinger (2015) The PyMOL Molecular Graphics System, Version 1.8"},{"key":"10.1186\/s43141-023-00583-w_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6807-5-14","article-title":"The Ramachandran plots of glycine and pre-proline","volume":"5","author":"Ho","year":"2005","journal-title":"BMC Struct Biol"},{"key":"10.1186\/s43141-023-00583-w_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2017.08.030","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","volume":"68","author":"Ioannou","year":"2018","journal-title":"J Hepatol"},{"key":"10.1186\/s43141-023-00583-w_bib49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hep.25800","article-title":"The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection","volume":"57","author":"Ioannou","year":"2013","journal-title":"Hepatology"},{"key":"10.1186\/s43141-023-00583-w_bib50","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/jvh.13746","article-title":"HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemic","volume":"29","author":"Hartl","year":"2022","journal-title":"J Viral Hepatitis"},{"key":"10.1186\/s43141-023-00583-w_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/liv.13659","article-title":"The impact of treatment of hepatitis C with DAA s on the occurrence of HCC","volume":"38","author":"Roche","year":"2018","journal-title":"Liver Int"},{"key":"10.1186\/s43141-023-00583-w_bib52","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Campreci\u00f3s J, Riveiro-Barciela M, Mu\u00f1oz-G\u00f3mez R, Londo\u00f1o M-C, Roget M, Serra M\u00c1, et al (2022) Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy. Gastroenterolog\u00eda y Hepatol","DOI":"10.1016\/j.gastrohep.2022.12.004"},{"key":"10.1186\/s43141-023-00583-w_bib53","unstructured":"CDC. Hepatitis C | CDC. Centers for Disease Control and Prevention 2021. https:\/\/www.cdc.gov\/hepatitis\/hcv\/index.htm. Accessed 8 Jan 2023"},{"key":"10.1186\/s43141-023-00583-w_bib54","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acsabm.1c01238","article-title":"Peptides for vaccine development","volume":"5","author":"Hamley","year":"2022","journal-title":"ACS Appl Bio Mater"},{"key":"10.1186\/s43141-023-00583-w_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4571-5","article-title":"A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice","volume":"19","author":"Dawood","year":"2019","journal-title":"BMC Infectious Diseases."},{"key":"10.1186\/s43141-023-00583-w_bib56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/jvh.12094","article-title":"Virus-neutralizing antibodies to hepatitis C virus","volume":"20","author":"Wahid","year":"2013","journal-title":"J Viral Hepatitis"},{"key":"10.1186\/s43141-023-00583-w_bib57","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/ijms12010226","article-title":"Computational docking of antibody-antigen complexes, opportunities and pitfalls illustrated by influenza hemagglutinin","volume":"12","author":"Pedotti","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1186\/s43141-023-00583-w_bib58","series-title":"Peptide toxicity prediction","first-page":"143","author":"Gupta","year":"2015"},{"key":"10.1186\/s43141-023-00583-w_bib59","doi-asserted-by":"crossref","first-page":"16931","DOI":"10.1074\/jbc.RA120.014761","article-title":"Cholesterol sensing by CD81 is important for hepatitis C virus entry","volume":"295","author":"Palor","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1186\/s43141-023-00583-w_bib60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ct900549r","article-title":"Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models","volume":"6","author":"Bjelkmar","year":"2010","journal-title":"J Chem Theory Comput"},{"key":"10.1186\/s43141-023-00583-w_bib61","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.28989","article-title":"The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs","volume":"65","author":"Vietheer","year":"2017","journal-title":"Hepatology"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-023-00583-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43141-023-00583-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23010053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23010053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-023-00583-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:58:32Z","timestamp":1761659912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X23010053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1687157X23010053"],"URL":"https:\/\/doi.org\/10.1186\/s43141-023-00583-w","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioinformatics analysis of multi-epitope peptide vaccines against Hepatitis C virus: a molecular docking study","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s43141-023-00583-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Academy of Scientific Research and Technology. Published by Elsevier BV.","name":"copyright","label":"Copyright"}],"article-number":"117"}}